Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Samsung Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with histologically confirmed metastatic colorectal cancer
Cetuximab-based chemotherapy (monotherapy, combination therapy with cytotoxic chemotherapy such as FOLFOX, XELOX, irinotecan, FOLFIRI, XELIRI, first-line, second-line or third-line are all eligible)
Age \> 18 years.
ECOG Performance Status of 0-2
Adequate bone marrow, liver and renal function
Signed and dated informed consent before the start of specific protocol procedures.
FNA will be performed in patients with feasible biopsy site; ascites or pleural fluid will be collected in metastatic CRC patients with ascites or pleural effusion
You may not be if
Active clinically serious infections (\> grade 2 CTCAE version 3.0)
Patients with evidence or history of bleeding diathesis
Radiotherapy during study or within 4 weeks of start of study drug.
Prior exposure to the study drug.
Substance abuse, medical, psychological or social conditions that may interfere with the patient's participation in the study or evaluation of the study results
